JENKINS GEORGE M

Director Jenkins buys 445 PVLA shares at $112.30; 3 of 3 prior PVLA purchases were well-timed at 90 days.

Jenkins George M, a director at Palvella Therapeutics, purchased 445 shares at $112.30 on March 30, 2026, bringing his holdings to 187.6K shares. His recent trade history at this ticker is notably consistent: three prior open-market buys all showed positive 90-day returns (+23.6%, +22.8%, and +115.5%), demonstrating precise execution timing at this company. However, context is mixed—the stock is currently down 9.2% over 30 days and 18.8% below its 52-week high of $148.34, and Palvella remains unprofitable with negative net income of $-11.3M despite 65.3% annual revenue growth. The timing pattern across Jenkins's prior trades at PVLA suggests precision in entry selection, but the current price action and unprofitability warrant attention to whether this purchase precedes a reversal or further pressure.

Director Jenkins purchases 4,000 PVLA shares at $125.00 for $500,000; stock now at $132.61, up 72.9% in 30 days.

Director George M. Jenkins purchased 4,000 shares of Palvella Therapeutics at $125.00, bringing his total holdings to 187,171 shares, in a $500,000.00 transaction. The purchase occurs at a notable moment: the stock trades at $132.61, reflecting a 72.9% surge over the past 30 days and a 44.8% gain over 90 days, though it remains 10.6% below its 52-week high of $148.34. Jenkins' prior PVLA transactions show consistently well-timed purchases—three earlier trades at this ticker each delivered positive 90-day returns (ranging from +23.6% to +115.5%), and his cross-ticker track record shows a 100% win rate on his 3 prior buys with an average 90-day return of +54.0%. The company remains unprofitable with a net income of $-11,345,000 in the latest quarter, despite strong annual revenue growth of +65.3%, creating a complex risk-reward backdrop for this accumulation at elevated price levels.

Director Jenkins George M bought 4,990 shares at blended avg $20.20 on 2025-04-09; holdings +58.5% vs pre-transaction.

Jenkins George M, a PVLA director, executed 2 separate purchases on 2025-04-09 totaling 4,990 shares for $100,797.30 at a blended average price of $20.20, increasing his holdings from 8,526 to 13,516 shares (+58.5%). The current price of $19.87 sits 31.5% below the 52-week high and 29.0% below the 30-day average, yet the stock has climbed 42.2% over the past 90 days. Notably, his single prior trade at PVLA (December 18, 2024 buy) delivered a 90-day return of +115.5%, aligning with a 100% win rate in his cross-ticker open-market history. The company remains unprofitable (net income $-2.9M in the latest period) despite 65.3% annual revenue growth, adding context to an insider accumulation at a time of elevated volatility and a material pullback from recent peaks.

Director Jenkins buys 4,000 shares of PVLA at $12.93; stock now trading at $12.00 post-IPO amid unprofitability.

Director George M. Jenkins purchased 4,000 shares at $12.93 on 2024-12-18, just days after PVLA's recent listing (4 trading days old). The stock has already declined to $12.00, placing the purchase $0.93 above current market price. Jenkins holds 180.7K shares post-transaction, a +2.3% increase in his ownership stake. The company is unprofitable (net income of $-2.9M in its most recent full fiscal year) with $0.00 revenue in the latest quarter, though it has demonstrated 65.3% year-over-year revenue growth on a very small base. As a newly listed micro-cap ($15.8M market cap), the stock's volatility and the company's path to profitability remain central questions for investors; an insider buy in the immediate post-IPO window by a director with material holdings warrants monitoring for the signals it may reveal about management's confidence in the near-term trajectory.